ICYMI: Trial Begins to Evaluate Savolitinib and IMFINZI for Renal Cell Carcinoma
Photo by Robina Weermeijer on Unsplash

ICYMI: Trial Begins to Evaluate Savolitinib and IMFINZI for Renal Cell Carcinoma

According to a news release, researchers from biopharmaceutical company HUTCHMED and pharmaceutical company AstraZeneca launched, at the onset of November 2021, the Phase 3 SAMETA clinical trial. During the trial,…

Continue Reading ICYMI: Trial Begins to Evaluate Savolitinib and IMFINZI for Renal Cell Carcinoma
Remembering Rachael Kaflowitz: One Mother’s Fight to Support NPC Research and Awareness (Pt. 2)
Courtesy of Debbie Kaflowitz

Remembering Rachael Kaflowitz: One Mother’s Fight to Support NPC Research and Awareness (Pt. 2)

In Part 1 of Rachael's story, I spoke with her mother Debbie about what Niemann-Pick type C (NPC) is, the beginning of the diagnostic journey, and how Dr. Behar helped…

Continue Reading Remembering Rachael Kaflowitz: One Mother’s Fight to Support NPC Research and Awareness (Pt. 2)

New Treatment For Alpha-1 Antitrypsin Deficiency Lung Disease Has Been Granted Orphan Drug Designation

Mereo BioPharma Group has just announced that they have received Orphan Drug Designation from the FDA for their new treatment for alpha-1 antitrypsin deficiency (A1AD) called alvelestat. This therapy is…

Continue Reading New Treatment For Alpha-1 Antitrypsin Deficiency Lung Disease Has Been Granted Orphan Drug Designation
Remembering Rachael Kaflowitz: One Mother’s Fight to Support NPC Research and Awareness (Pt. 1)
Courtesy of Debbie Kaflowitz

Remembering Rachael Kaflowitz: One Mother’s Fight to Support NPC Research and Awareness (Pt. 1)

“Hi, I’m Rachael, and I’m forever 33.” When Debbie Kaflowitz remembers her daughter, she thinks about everything that Rachael loved to do. Rachael enjoyed dancing and performing in ballet recitals,…

Continue Reading Remembering Rachael Kaflowitz: One Mother’s Fight to Support NPC Research and Awareness (Pt. 1)
The Porphyria Symposium: Claire’s Experience, and How Conferences Can Better Incorporate The Patient Perspective
source: pixabay.com

The Porphyria Symposium: Claire’s Experience, and How Conferences Can Better Incorporate The Patient Perspective

Claire Richmond lives with acute hepatic porphyria (AHP). She searched for 19 years to find answers to her unexplained pain. She wasn't diagnosed until she was 32. She recently had…

Continue Reading The Porphyria Symposium: Claire’s Experience, and How Conferences Can Better Incorporate The Patient Perspective
Study Finds Systemic Mastocytosis Patients Without CMIHR History Don’t Need Premedication Prior to Imaging
source: pixabay.com

Study Finds Systemic Mastocytosis Patients Without CMIHR History Don’t Need Premedication Prior to Imaging

Results from a study on systemic mastocytosis (SM) have recently been published. This investigation aimed to understand the prevalence of contrast media induced hypersensitivity reactions (CMIHR) in different subtypes of…

Continue Reading Study Finds Systemic Mastocytosis Patients Without CMIHR History Don’t Need Premedication Prior to Imaging
Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy
vitalworks / Pixabay

Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy

  According to a recent article, researchers investigated the cause of deaths in the hospital in patients who were diagnosed with inflammatory myositis in a tertiary care center in Northern…

Continue Reading Infections Are Leading Cause of Hospital Death in Indian Patients with Inflammatory Myopathy
Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?
source: pixabay.com

Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?

  When you are looking for new treatments that will either stop or slow the development of Alzheimer’s disease, where would you look? According to a recent article in Gladstone…

Continue Reading Alzheimer’s: A 50-year-old FDA Approved Diuretic Restored Normal Brain Activity in Mice; Will It Work On Humans?
Patient Worthy’s One-Year-Checkup on Victoria Gray, the First Sickle Cell Disease Patient to Receive CRISPR in the US
source: pixabay.com

Patient Worthy’s One-Year-Checkup on Victoria Gray, the First Sickle Cell Disease Patient to Receive CRISPR in the US

   CRISPR is a gene-editing technique that has revolutionized the medical world with its approach to making precise changes in DNA. CRISPR found its match in 35-year-old Victoria Gray of…

Continue Reading Patient Worthy’s One-Year-Checkup on Victoria Gray, the First Sickle Cell Disease Patient to Receive CRISPR in the US
PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome
Source: Pixabay

PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome

  According to a recent article, PharmaTher Holdings Ltd. announces the FDA granted orphan drug designation (ODD) for ketamine in the treatment of complex regional pain syndrome (CRPS). Complex Regional…

Continue Reading PharmaTher Announces the FDA Granted Orphan Drug Designation for Ketamine to Treat Complex Regional Pain Syndrome